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Abstract
Despite the importance of juxtaglomerular (JG) cell recruitment in the pathophysiology of 
cardiovascular diseases, the mechanisms that underlie renin production under conditions of 
chronic stimulation remain elusive. We have previously shown that CD44+ mesenchymal-like 
cells (CD44+ cells) exist in the adult kidney. Under chronic sodium deprivation these cells are 
recruited to the JG area and differentiate to new renin-expressing cells. Given the proximity of 
macula densa (MD) to the JG area and the importance of MD released prostanoids in renin 
synthesis and release, we hypothesized that chronic sodium deprivation induces MD release of 
prostanoids; stimulating renal CD44+ cell activation and differentiation. CD44+ cells were 
isolated from adult kidneys and co-cultured with the MD cell line, MMDD1, in normal or low 
sodium medium. Low sodium stimulated PGE2 production by MMDD1 and induced migration of 
CD44+ cells. These effects were inhibited by addition of a Cox-2 inhibitor (NS398) or an EP4 
receptor antagonist (AH23848) to MMDD1 or CD44+ cells respectively. Addition of PGE2 to 
CD44+ cells increased cell migration and induced renin expression. In vivo activation of renal 
CD44+ cells during JG recruitment was attenuated in wild type mice subjected to salt restriction in 
the presence of Cox-2 inhibitor Rofecoxib. Similar results were observed in EP4 receptor 
knockout mice subjected to salt restriction. These results show that the PGE2/ EP4 pathway plays 
a key role in the activation of renal CD44+ MSC-like cells during conditions of JG recruitment; 
highlighting the importance of this pathway as a key regulatory mechanism of JG recruitment.
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INTRODUCTION
The renin-angiotensin aldosterone system plays a key physiological role in the regulation of 
blood pressure, electrolyte homeostasis and kidney development. Renin is an aspartyl 
protease that catalyzes the first and rate limiting step in the activation of the Renin 
Angiotensin System (RAS). Factors regulating renin expression have the potential to 
significantly impact overall RAS activity and potentially can lead to novel therapeutic 
targets for RAS and cardiovascular/renal disease.
The primary source of renin in the circulation is the kidney. In the adult kidney renin 
expression is restricted to the terminal portion of the afferent arterioles in the 
juxtaglomerular (JG) area and is expressed in specialized cells termed JG cells. Despite this 
restricted expression of renin in the adult kidney, environmental stimuli, such as chronic 
ischemia, prolonged adrenergic activation, volume and sodium depletion, produce an 
increase of the number of cells expressing renin along the afferent arteriole, in the 
interstitium and inside the glomerulus, in a pattern partially recapitulating embryonic 
distribution of renin expression1, 2. This process, known as JG recruitment 2, involves re-
expression of renin in renal smooth muscle cells (VSMCs) along the arteriole 2 and 
differentiation of pericytes 3 and adult CD44+ mesenchymal-like cell populations to renin 
expressing cells 4. Despite the importance of this mechanism in regulating renin, the exact 
cellular processes, as well as the identities of local mediators and cellular receptors involved, 
are not fully understood.
The macula densa (MD) is an area of highly specialized cells at the thick ascending limb of 
the loop of Henle that are located adjacent to the afferent arterioles where they are in a 
unique position to affect changes within the JG area. Indeed, it is well established that in 
response to salt restriction, MD cells secrete molecules that directly regulate renin 
expression and release 5-7. Among them, PGE2 derived from the Cox-2/ prostaglandin 
synthase cascade plays a central role 8, 9. PGE2 acts via a class of EP1-4 receptors. From 
those, EP4 is of prime importance for renin regulation 10-13.
Several studies have shown that stem cell/progenitor like cells exist in the adult kidney and 
that these cells are activated under conditions of injury of physiological stress14, 15. Our 
laboratory has recently shown that CD44+ mesenchymal-like cells (CD44+ cells) exist in 
the adult kidney4. Under conditions of salt restriction these cells are activated, accumulate in 
the JG area and differentiate to renin expressing cells4. Here, we tested the hypothesis that 
MD-derived prostanoids by stimulating the receptors on renal CD44+ cells are crucial for 
their activation and differentiation to renin expressing cells under conditions of salt 
restriction.
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PGE2, EP4 receptor antagonist (AH23848), PGI2 and IP receptor antagonist (CAY10441) 
were purchased from Cayman Chemical; Forskolin (FSK), 1-Methyl-3-isobutylxanthine 
(IBMX), N-[2-(cyclohexyloxy)-4-nitrophenyl]-methanesulfonamide (NS398) and 
Lipopolysaccharide (LPS) from Sigma. Cell DMEM was purchased from Sigma and the 
MesenCult® Proliferation Kit from Stem Cell Technology.
MMDD1 cells
MMDD1, a renal epithelial cell line with properties of macula densa cells (e.g., expression 
of cyclooxygenase 2 (Cox-2), and NKCC2), were kindly supplied by Dr. J. Schnermann 
(National Institutes of Health)16. The cells were routinely maintained in DMEM/nutrient 
mixture Ham's F-12, supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin 
(100 mg/mL), incubated at 37 °C in the presence of 5% CO2. The medium was changed 
every 2 days. Where necessary, MMDD1 cells were exposed to a reduced extracellular NaCl 
concentration. Here, confluent MMDD1 monolayers were exposed to serum-free Dulbecco's 
modified Eagle's medium in a 1:1 mixture with isotonic saline (control) and 300 mM 
mannitol to reduce NaCl concentration to one-half as described in Yang et al16.
Isolation and culture of renal progenitor cells
Renal CD44+ MSCs were isolated from mice kidneys as described 4. Briefly, kidneys were 
perfused in vivo with saline and then harvested, minced, and digested with 0.1% collagenase 
type I for 30 min at 37°C. The cell suspensions were washed and filtered through 70-μm and 
40-μm mesh filters, and residual red blood cells removed by treatment with cold ACK buffer 
(0.15 M potassium-ammonium chloride). CD44+ cells were isolated by two cycles of FACS 
sorting via specific gates. Dead cells were excluded with 7AAD (7-Aminoactinomycin D), 
doublets were excluded on the basis of three hierarchical gates (forward/side scatter area, 
forward scatter height/width, and side scatter height/width). Renal CD44+ cells collected by 
FACS were cultured in growth medium MesenCult® Proliferation Kit (stem cell 
technology) at 37 °C in the presence of 5% CO2. Medium was changed every 2-3 days. 
Cells were used for experiments during passages 3-5.
RT-PCR and quantitative RT- PCR
The mRNA levels of all the genes checked in this study were quantified by RTPCR and 
quantitative RT-PCR. Total RNA was isolated from tissues or cells using Trizol reagent 
according to manufacturer's recommendations (Invitrogen). First strand cDNA was 
synthesized from 2 μg of total renal RNA using the Omniscript RT kit (Qiagen), and oligo-
dT as the primer. 2 μL per reaction of cDNAs were used as the template for real-time PCR 
amplification. Quantitative RT-PCR was carried out using ABI Prism 7700 Applied 
Biosystems Sequence Detection System and SYBR Green PCR kit (Qiagen) or TaqMan 
probe set and TaqMan PCR kit (Applied Biosystems).
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In vitro cell differentiation
The differentiation assay was performed as described 17. Briefly, 8-Bromo adenosine 3’, 5’-
cyclic monophosphate cAMP (1 mM), 3-Isobutyl-1-Methylxanthine (IBMX) (0.1 mM), or 
vehicle control (DMSO) were added to culture media daily during the treatment period. In 
differentiated C57BL/6 Ren1c-YFP renal CD44+ cells, the renin expression was determined 
by fluorescence microscopy, using YFP expression as a surrogate for renin expression.
Immunofluorescence or immunohistochemical staining
Immunohistochemistry of kidney sections (5 microns thick) was performed using standard 
procedures. Kidney tissue sections were fixed in 4% paraformaldehyde and permeabilized 
with 0.2% Triton X-100. After blocking with 5% serum/PBS for 1 h, sections were 
incubated with primary antibodies diluted in 5% serum/PBS overnight at 4°C. Slides 
subsequently were washed in PBS and incubated with secondary fluorochrome-conjugated 
antibodies for 45 min. The following primary antibodies were used: anti-CD44 
(immunohistochemistry: BioLegend, #103001, 1/50 dilution, immunofluorescence: Abcam 
#ab6124, 1/100dilution), sheep anti-renin (immunohistochemistry: Innovative Res 1206, 
1/100 dilution) or rabbit anti-renin (immunofluorescence: 1/10000 dilution, kindly provided 
by Dr. Tadashi Inagami, Vanderbilt University. The following secondary antibodies were 
used at a 1:500 dilution for 45 minutes-1h at room temperature: Alexa 488 goat anti-rabbit 
IgG (A-11008), Alexa 594 goat anti-rabbit IgG (A-11012), Alexa 594 goat anti-rat IgG 
(A-11007), Alexa 633 donkey anti-sheep IgG (A-21100). Secondary antibodies were 
purchased from Invitrogen. Nuclei were counterstained with DAPI. Kidneys were embedded 
into OCT compound (Optimal Cutting Temperature compound), coronal sectioned, and 
5micron slices cut. Confocal images were taken in the cortex and acquired with a LSM 510 
Meta DuoScan microscope (Zeiss) and processed using LSM 5 software, version 4.2. 
Images were acquired and analyzed by a blinded investigator. N=3-4 animals per group, 3-4 
tissue slices per kidney, 3-4 images per tissue slice. Quantification was performed in Image 
J.
Cell Migration Assay
Migration of CD44+ cells was assessed using 24-well plates with Transwell inserts (8.0 um 
pore; Costar), as described18. MMDD1 cells were seeded in 24 well plates at 25×105 cells/ 
well. Once the MMDD1 cells had attached to the plastic, the MMDD1 cells were the serum 
starved for 18h. The MMDD1 cells were then primed for Cox-2 expression by overnight 
incubation with low salt medium. Where appropriate the Cox-2 inhibitor was added during 
the overnight incubation in low salt medium. The following day Transwell inserts containing 
CD44+ MSCs were set up for migration assays in serum-free normal-salt DMEM media 
supplemented 1x Penicillin-Streptomycin. Renal CD44+ MSCs were pretreated with various 
inhibitors as indicated.
Immunoblotting
Immunoblotting was performed as described 19. Protein lysates were prepared with 
radioimmunoprecipitation assay (RIPA) buffer (50mM Tris pH 7.8, 150mM NaCl, 0.5% Na 
deoxycholate, 1% Triton X-100) containing protease inhibitors (Roche). Denatured proteins 
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(20-40μg) were separated by SDS-polyacrylamide gel electrophoresis, and transferred onto 
PVDF. Blocking and antibody incubation was performed with 5% nonfat dry milk in TBS-
Tween (62.5mM Tris pH7.5, 150mM NaCl, 0.1% Tween-20). Rabbit anti-murine polyclonal 
antibody to EP4 was used at a dilution of 1:1000. Visualization of the bands was performed 
with a goat anti-rabbit horseradish peroxidase-conjugated secondary antibody (Cell 
Signaling, 1:1000) and ECL-Prime(GE Healthcare).
Animal Studies
Male C57BL/6 wild type mice 6-8 weeks of age (Charles River Laboratories), male 
C57BL/6 Ren1c-YFP mice 6-8 weeks of age (kindly provided by Dr. Gomez at University 
of Virginia Medical Center), and 6-8 week recombinant inbred (RI) background EP4−/− and 
their co-isogenic controls kindly provided by Dr. Coffman at Duke University and Dr. 
Beverly Koller at University of North Carolina) were used for the mouse studies. The 
generation and maintenance of EP4−/− mice has been reported previously 16. On a C57BL/6 
background EP4−/− die postnatally as a result of patent ductus arteriosus. Therefore, a RI 
strain was generated by >35 generations of successive intercross of EP4 +/− mice of mixed 
genetic background composed of 129P2C57BL/6, and DBA/2 alleles. EP4−/− and their 
congenic wild type controls were identified at weaning and co-housed for the duration of the 
experiment. All the animals were maintained on a 12-hour light/12-hour dark cycle at an 
ambient temperature of 24°C and 60% humidity. Food and water were provided as indicated 
in each experiment. For low salt diet plus Furosemide administration (in drinking water - 
2.28 mmol/L), animals were placed on a low salt diet (0.02% NaCl) for 10 days. Control 
animals received normal chow (0.4% NaCl). All animal procedures were approved by the 
Institutional Animal Care and Use Committees at Duke University. For low salt diet plus 
Cox-2 inhibitor administration, animals were placed on a low sodium diet (0.02% NaCl) 
with Cox-2 inhibitor 62.5mg/kg and furosemide in drinking water for 10 days.
Statistical Analysis
All the results are presented as the mean ± SEM. All of the experiments were performed in 
triplicate and repeated 3 to 4 times. ANOVA with Bonferroni correction was used to 
determine significance. Graphs are displayed as mean ± SEM
RESULTS
PGE2 promotes CD44+ MSC migration and renin expression
To investigate the effects of prostanoids on adult renal mesenchymal-like cells, we treated 
renal CD44+ mesenchymal-like cells (CD44+ cells) directly with PGE2 or PGI2 and tested 
effects on cell proliferation, migration and differentiation to renin expressing cells. CD44+ 
cells were isolated from kidneys of adult male C57BL/6 wild type mice by Fluorescence 
Activated Cell Sorting (FACS) and cells were passaged 3-5 times before use. To study the 
effects of PGE2 on migration we performed transwell migration assays using a Boyden 
chamber. Renal CD44+ cells were seeded on the upper layer of the cell permeable 
membrane and treated overnight with different concentrations of PGE2 or PGI2 (1-1000 
nM). 24 hours later, the number of cells which had migrated through the membrane to the 
bottom well was quantified. Treatment with PGE2, but not PGI2, resulted in significantly 
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increased migration of CD44+ cells I (Figure 1A). PGE2 did not affect CD44+ cell 
proliferation at the concentrations tested (Figure 1B). CD44+ cells isolated from Ren1c-YFP 
were treated with PGE2 for 10 days and then examined under immunofluorescence 
microscopy for YFP expression. We found that prolonged treatment of CD44+ cells with 
high doses of PGE2 (10μM) induced renin expression (Figure 1C). No YFP was detected in 
vehicle treated cells. YFP and renin were found to co-express in the same cells validating 
the YFP model (Figure S1A). Moreover, PGE2 increased renin expression in wild-type 
CD44+ cells (Figure S1B). Collectively, these data demonstrate that PGE2 enhances renal 
CD44+ cell migration and differentiation to renin expressing cells.
PGE2 promotes CD44+ MSC migration and renin expression via the EP4 receptor
The above results suggested that PGE2, but not PGI2, induces migration and differentiation 
of CD44+ cells. Since PGE2 has been shown to stimulate renin via activation of E-
Prostanoid receptor 2 and 4 (EP2 and EP4) 20, we first examined the expression of these 
genes in renal CD44+ cells. CD44+ cells were isolated from kidneys of adult male C57BL/6 
wild type mice by FACS and mRNA was isolated. As a control, mRNA was isolated from 
vehicle or LPS treated J774 macrophage cell line. CD44+ cells were found to express the 
EP4 but not the EP2 receptor as determined by RT-PCR (Figure 2A). This result was 
subsequently validated by qRT-PCR (Figure 2B, 2C) and expression of EP4 protein was 
confirmed by immunoblotting (Figure 2D). EP2 expression was either very low or not 
detectable in CD44+ and CD44- cells (Figures 2A, 2B, 2C).
To determine the importance of EP4 receptor in CD44+ cell biology, we pretreated renal 
CD44+ cells with an EP4 antagonist prior to PGE2 treatment. Migration was examined 
using the transwell Boyden chamber. Similar to the data in Figure 1, PGE2 induced a 2-fold 
increase in migration while the EP4 antagonist AH23848 significantly attenuated PGE2 
induced renal CD44+ cell migration (Figure 3A). Moreover, when renal CD44+ cells were 
isolated from mice lacking the EP4 receptor 13, the effect on PGE2 on CD44+ cell migration 
was abrogated (Figure 3B). Similarly, pretreatment of the CD44+ cells with AH23848 
abolished the effects of PGE2 in renin induction of these cells (Figures 3C and 3D). The 
results show that PGE2 induces renal CD44 + cell migration and differentiation to renin 
expressing cells through the EP4 receptor.
Macula densa derived PGE2 activates adult renal CD44+ in vitro via the EP4 receptor
The macula densa is an important source of PGE2 and plays a major role in the regulation of 
JG renin expression and release during changes in salt intake5. To study the macular densa 
mediated effects on the CD44+ cell in vitro we used the MMDD1 cell line. To enhance 
secretion of PGE2, the MMDD1 cells were incubated with DMEM medium with reduced 
sodium chloride (67mM)16 where appropriate. Serum-starved renal CD44+ MSCs were 
plated on transwell inserts and the inserts placed into the wells containing the MMDD1 
cells. The co-culture was conducted in normal-salt DMEM without serum and CD44+ cells 
were allowed to migrate through the filters at 37°C overnight. Overnight co-culture of renal 
CD44+ cells with MMDD1 cells exposed to low salt conditions, increased CD44+ cell 
migration by two-fold as measured using transwell Boyden chamber migration assays when 
compared to co-culture of renal CD44+ cells with MMDD1 cells exposed to normal salt 
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conditions (Figure 4). This effect on migration was abrogated by addition of a Cox-2 
inhibitor (NS398), which blocks PGE2 production in MMDD1 cells, or by addition of the 
EP4 receptor antagonist AH23848 to the CD44+ cells (upper chamber) (Figure 4). 
Treatment of the CD44+ cells with a PGI2 receptor antagonist (CAY 10441) had no effect 
on this migratory response (Figure 4), demonstrating that PGE2 secreted from the MMDD1 
cells is the prostanoid affecting the CD44+ cell migration and confirming that these effects 
are mediated via the EP4 receptor.
Cox-2 inhibition blocked renal CD44+ cell activation in vivo after low salt and Furosemide 
treatment
Next, to investigate whether the Cox-2 and PGE2 mechanisms played a role in renal CD44+ 
RPC activation in vivo, wild type C57BL/6 mice were subjected to salt restriction by low 
salt diet and furosemide treatment 4 (2.28 mmol/L, drinking water) for 10 days in the 
presence or absence of the Cox-2 inhibitor Rofecoxib 21 (62.5mg/kg). Low salt diet 
increased plasma renin concentration (Figure S2). This increase in plasma renin 
concentration was significantly inhibited by Rofecoxib (Figure S1). Kidneys were harvested 
and processed for immunofluorescent microscopy using CD44 and renin specific antibodies. 
As anticipated from previous studies 4, salt restriction resulted in increased renin expression 
and JG cell number, as well as an increase in the number of CD44+ cells (Figure 5A, with 
quantification provided in Figures 5B and 5C). However, in Rofecoxib treated mice, both 
renin expression and the number of CD44+ cells were significantly attenuated (Figure 5A, 
with quantification provided in Figures 5B and 5C). These results suggest that PGE2 is 
important for the activation of renal CD44+ cells during salt restriction-induced JG cell 
recruitment.
EP4 receptor is essential for renal CD44+ cell activation in vivo after low salt and 
Furosemide treatment
To investigate the importance of EP4 receptor in the CD44+ cell activation after salt 
restriction in vivo, we employed EP4 knockout mice 13. As described in the previous 
section, mice were treated with a low salt diet and furosemide for 10 days. At the end of 
treatment, kidneys were harvested and CD44 and renin expression examined by 
immunofluorescent microscopy. As shown in Figures 6 A-C, in wild type mice, low salt and 
furosemide treatment resulted in an increase in both renin expressing cells and the number 
of CD44+ cells. These responses were significantly attenuated in the EP4 knockout mouse 
kidney from EP4−/− mice (Figure 6 A-C). These results demonstrate the importance of EP4 
receptor in PGE2 induced CD44+ activation in vivo.
DISCUSSION
Several studies have shown that stem cell/progenitor cells exist in the adult kidney and are 
activated following sustained stress or injury 14, 15. Our laboratory has recently shown that 
adult renal CD44+ MSC-like cells act as renin progenitor cells 4. These CD44+ cells are 
activated during conditions of sodium constriction and contribute to the increased renin 
response by accumulating in the JG area and differentiating to renin producing cells4.
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In the current study we extend these findings and illustrate that adult renal CD44+ cells 
express EP4 receptors and that co-culture of MMDD1 cells with adult renal CD44+ cells 
stimulate migration of CD44+ cells; the effect was attenuated with treatment of MMDD1 
cells with Cox-2 inhibitor or treatment of the CD44+ cells with an EP4 antagonist. Direct 
exposure to PGE2 increased CD44+ cell migration in an EP4 dependent manner. In addition, 
our results indicated that treatment of CD44+ cells with higher doses of PGE2 induced renin 
expression in vitro. Finally, both the activation of renal CD44+ and the increase in renin 
expression in response to salt restriction are diminished in mice lacking the EP4 receptor 
gene. Since CD44+ cells loose CD44 expression concurrent with an increase in renin 
expression, it is difficult to find CD44/Renin double positive cells in vivo, however, 
previous lineage tracing studies have shown that the CD44+ cells are a precursor to the renin
+ cells7. Thus, taken together, our data supports the novel concept that renal stem/progenitor 
cells contribute to the process of JG recruitment and suggest that MD, via the secretion of 
PGE2 and activation of the EP4 receptor on the renal progenitor cells, are involved in this 
process.
It is well established that MD derived prostaglandin E2 (PGE2) is one of the principal 
mediators of local control of renin release in the kidney 9. According to the classic 
paradigm, MD cells sense salt and/or other biochemical signals that induce the production of 
PGE2 9. PGE2 acts on EP2 or EP4 receptors in JG cells and stimulates renin release20; 
although more recent evidence supports the notion that EP4 is the receptor responsible in 
mediating the PGE2 induced renin release under conditions of salt restriction in vivo 13. Our 
data suggests that the MD/PGE2/EP4 axis plays a broader role in renin regulation by 
promoting renin expression in CD44+ cells in the adult kidney. Indeed, PGE2 has recently 
gained much attention as a mediator of in vitro and in vivo migration and differentiation of 
hematopoietic stem cells, endothelial progenitor cells and mesenchymal stem cells 22-24. Our 
studies provides additional insights into the role of PGE2 in stem cell biology and, to our 
knowledge, provides the first such evidence for PGE2 affecting the fate of renal stem cells. 
Future experiments to discern how a PGE2 dose gradient affects renin expression during salt 
restriction in adult or during renal development, as well as elucidating the downstream 
pathways involved, would be of high interest. For example, Len Zon and colleagues have 
demonstrated that PGE2 affects hematopoietic stem cell biology by the cAMP dependent 
activation of the Wnt signaling pathway 24. Moreover, cAMP is a known regulator of 
transcription and an examination of the transcription factors and transcripts regulated by 
cAMP in CD44+ cells following exposure to PGE2 may identify targets for future study.
Although our studies highlight the role of MD/PGE2/EP4 axis we cannot exclude that other 
molecules or receptors such as PGI2, nitric oxide, IP receptor receptors play a role in vivo 10 
and might be involved in the CD44+ cell response during salt restriction. Indeed, although 
PGE2 treatment did not affect CD44+ cell proliferation in vitro, Cox-2 inhibition was 
sufficient to abrogate the CD44+ cell expansion after low sodium furosemide treatment in 
vivo. Similar results were obtained from with EP4 receptor knock out mice. Similarly, we 
cannot exclude that the MD/PGE2/EP4 mechanisms affect other cellular processes involved 
in JG recruitment. JG recruitment involves several mechanisms such as proliferation of the 
existing renin-expressing JG cells, induction of renin expression in vascular smooth muscle 
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cells of the afferent arteriole 2, 25, and transdifferentiation of pericytes 3. Studying the effects 
of MD/PGE2/EP4 upon these pathways would be of great interest.
PERSPECTIVES
Our data shows the activation of renal stem/progenitor cells in response to salt restriction 
requires PGE2/EP4. These studies provide new insights about role of renal stem cells in 
renal physiology and diseases as well as advancing our understanding regarding JG 
recruitment and regulation of the renin angiotensin system.
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1. What is New?
• PGE2 released by a macula densa cell line under conditions of low 
sodium induced CD44+ cell migration; an effect inhibited by an EP4 
receptor antagonist.
• In vivo, genetic ablation of EP4 or inhibition of Cox-2 by Rofecoxib 
attentuated the ability of low sodium to induce both renal CD44+ cell 
activation during JG recruitment and the production of renin.
2. What is relevant?
• Juxtaglomerular (JG) cell recruitment is important in the pathophysiology 
of hypertension; however mechanisms that underlie renin production 
under conditions of chronic stimulation are relatively unknown.
• We have previously shown that CD44+ mesenchymal-like cells exist in 
the adult kidney. Under chronic sodium deprivation these cells are 
recruited to the JG area where they differentiate into new renin-
expressing cells.
3. Summary
• The PGE2/EP4 pathway is a key regulatory mechanism of JG 
recruitment.
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Figure 1. PGE2 promotes CD44+ cell migration and differentiation in vitro
(A) Renal CD44+ MSC-like cell migration was measured by transwell Boyden Chamber 
assay. Cells were treated with 0, 10nM, 100nM, or 1μM of PGE2 or PGI2. The data is 
shown as a fold change where the number of migrated CD44+ cells in the vehicle control 
was taken to be 1. N=3. Comparisons are made to the vehicle control **P<0.01.
(B) CD44+ MSC-like cell proliferation was measured by MTS assay. Cells were seeded in 
96 wells plates and treated with 0, 10nM, 100nM or 1 μM of PGE2 for 3 days. The data is 
shown as a fold change, with MTS absorbance in the vehicle control taken to be 1. N=3. 
Comparisons made to the vehicle control, ns: not significant.
(C) C57BL/6 renin 1c YFP mouse renal CD44+ cells were treated with 10μM PGE2 for 10 
days. YFP was used as a surrogated marker for renin expression. Representative experiment 
shown.
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Figure 2. Expression of EP2 and EP4 receptors in renal CD44+ cells
(A) RT-PCR for EP2 or EP4 receptor expression. GAPDH was used as a loading control. 
EP2, EP4 and GAPDH bands were 554, 560 and 516bp in size respectively. CD44+: CD44+ 
cells; J774: macrophage cell line. LPS treatment was used as a positive control to up-
regulate expression of EP2 and EP4 receptors in the J774 cell line. Representative 
experiment shown.
(B) Expression of EP2 and EP4 mRNA in CD44+ cells detected by qRT-PCR. Gene 
expression data is shown relative to GAPDH. MSC: renal CD44+ MSC-like cells; J774: 
macrophage cell line; H2O: Negative control.
(C) Expression of EP2 and EP4 mRNA in CD44+ and CD44- cells as determined by qPCR. 
Gene expression data is shown relative to GAPDH. N=3.
(D) Immunoblot for EP4. Representative images are shown.
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Figure 3. PGE2 promotes CD44+ cell migration and differentiation via EP4 receptor
(A) Renal CD44+ cell migration was measured by transwell Boyden Chamber assay. Cells 
were treated with PGE2 (1μM) in the presence or absence of 10μM AH23848, an EP4 
receptor inhibitor. The data is shown as a fold change where the number of migrated CD44+ 
cells in the vehicle control was taken to be 1. N=3. Comparisons made to the vehicle control 
**P<0.01.
(B) Renal CD44 cells were isolated form EP4 −/− mice. The EP4 −/− renal CD44+ MSCs 
were treated with PGE2 1μM overnight and migration was measured by transwell Boyden 
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Chamber assay. The data is shown as a fold change where the number of migrated CD44+ 
MSC-like cells in the vehicle control was taken to be 1. N=3. P=0.52 ns, not significant.
(C) Renal CD44+ cells isolated from Ren1c-YFP were treated with PGE2 (10μM) for 10 
days in the presence or absence 10μM AH23848, and then examined under 
immunofluorescence microscopy for YFP expression as a surrogate marker for renin 
expression. Representative merged bright field and fluorescent images are shown. Forskolin 
(FSK) and IBMX treatment were used as positive control for renin induction.
(D) Quantitative analysis of (C). Data are presented as mean + SE of 3 experiments each 
with at least three samples per condition. Comparisons made to DMSO, **P<0.01.
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Figure 4. Cox-2 Inhibition abrogates MD cell induced CD44+ cell migration In Vitro
MMDD1 cells (25×104 cells/ well) were seeded in a 24 well plate and cultured overnight in 
normal or low sodium medium (to induce Cox-2 expression) in the presence or absence of 
Cox-2 inhibitor NS398 10μM. Low salt medium was used to induce Cox-2 expression in the 
MMDD1 cells. Serum-starved renal CD44+ cells (1×105) were plated on the transwell 
inserts and inserts were placed in the wells containing the MMDD1 cells. The co-culture 
was conducted in normal-salt DMEM without serum. CD44+ cells were allowed to migrate 
through the filters at 37°C overnight. AH23848 (EP4 receptor antagonist) 10μM and 
CAY10441 (PGI2 receptor antagonist) 10μM were added where appropriate. N=3. 
Comparisons made to the vehicle control in normal sodium media * p<0.05.
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Figure 5. Pharmacological inhibition of Cox-2 blocked renal CD44+ cell activation in vivo after 
low salt/Furosemide treatment
Wild Type C57BL/6 mice were administered a normal salt diet with vehicle or low salt diet 
accompanied by furosemide treatment for 10 days with or without the Cox-2 inhibitor 
Rofecoxib.
(A) Representative confocal images of kidney sections immunostained for CD44 [red] and 
renin [green], and nuclei [DAPI, blue] from low sodium and furosemide treated and control 
untreated mice. Scale bar 100 microns.
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(B) The number of CD44+ cells and glomeruli were counted. The total number of glomeruli-
associated CD44+ cells was divided by the total number of glomeruli. The value in the 
normal diet vehicle control group was taken to be 1. Comparisons made to either the normal 
diet vehicle control group * p<0.05, or between the vehicle and Rofecoxib groups treated 
with low sodium and furosemide ‡ p<0.05. N=3-4 per group.
(C) The area of renin immunostaining was quantified by Image J. The value in the normal 
diet vehicle control group was taken to be 1. Comparisons made to either the normal diet 
vehicle control group * p<0.05, or between the vehicle and Rofecoxib groups treated with 
low sodium and furosemide ‡ p<0.05. N=3-4 per group.
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Figure 6. Renal CD44+ cell activation is attenuated in EP4 knockout mice treated with low salt /
Furosemide
EP4 knockout mice were administered a normal salt diet with vehicle or low salt diet 
accompanied by furosemide treatment for 10 days.
(A) Representative confocal images of kidney sections immunostained for CD44 [red] and 
renin [green], and nuclei [DAPI, blue] from low sodium and furosemide treated and control 
untreated mice. Scale bar 100 microns.
(B) The number of CD44+ cells and glomeruli were counted. The total number of glomeruli-
associated CD44+ cells was divided by the total number of glomeruli. The value in the 
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normal diet vehicle control group was taken to be 1. Comparisons made to either the normal 
diet vehicle control group * p<0.05, or between the vehicle and Rofecoxib groups treated 
with low sodium and furosemide ‡ p<0.05. N=3-4 per group.
(C) The area of renin immunostaining was quantified by Image J. The value in the normal 
diet vehicle control group was taken to be 1. Comparisons made to either the normal diet 
vehicle control group * p<0.05, or between the vehicle and Rofecoxib groups treated with 
low sodium and furosemide ‡ p< 0.05. N=3-4 per group.
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